DE60326220D1 - Verfahren zur herstellung von einer 2-18f-fluor-2-deoxy-d-glucose (18fdg)-lösung - Google Patents

Verfahren zur herstellung von einer 2-18f-fluor-2-deoxy-d-glucose (18fdg)-lösung

Info

Publication number
DE60326220D1
DE60326220D1 DE60326220T DE60326220T DE60326220D1 DE 60326220 D1 DE60326220 D1 DE 60326220D1 DE 60326220 T DE60326220 T DE 60326220T DE 60326220 T DE60326220 T DE 60326220T DE 60326220 D1 DE60326220 D1 DE 60326220D1
Authority
DE
Germany
Prior art keywords
deoxy
glucose
solution
fdg
fluor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326220T
Other languages
English (en)
Inventor
Petrus Simon Kruijer
Castro Hector Humberto Knight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DE60326220D1 publication Critical patent/DE60326220D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60326220T 2002-04-24 2003-04-23 Verfahren zur herstellung von einer 2-18f-fluor-2-deoxy-d-glucose (18fdg)-lösung Expired - Lifetime DE60326220D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076638A EP1356827A1 (de) 2002-04-24 2002-04-24 Verfahren zur Herstellung von einer 2-18F-Fluor-2-Deoxy-D-Glucose (18F-FDG)-Lösung
PCT/US2003/012603 WO2003090789A1 (en) 2002-04-24 2003-04-23 Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose (18f-fdg) - solution

Publications (1)

Publication Number Publication Date
DE60326220D1 true DE60326220D1 (de) 2009-04-02

Family

ID=28685968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326220T Expired - Lifetime DE60326220D1 (de) 2002-04-24 2003-04-23 Verfahren zur herstellung von einer 2-18f-fluor-2-deoxy-d-glucose (18fdg)-lösung

Country Status (13)

Country Link
US (1) US8182788B2 (de)
EP (2) EP1356827A1 (de)
JP (2) JP5132869B2 (de)
KR (1) KR20050005456A (de)
CN (1) CN1323724C (de)
AT (1) ATE422903T1 (de)
AU (1) AU2003225124B2 (de)
CA (1) CA2483181C (de)
DE (1) DE60326220D1 (de)
IL (2) IL164805A0 (de)
NO (1) NO329160B1 (de)
PL (1) PL371682A1 (de)
WO (1) WO2003090789A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
US20080193379A1 (en) * 2005-06-14 2008-08-14 Nihon Medi-Physics Co., Ltd. Radioactive Diagnostic Imaging Agent
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
KR20090025282A (ko) * 2006-06-21 2009-03-10 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
EP2029182A2 (de) 2006-06-21 2009-03-04 GE Healthcare AS Stabilisierung von radiopharmazeutischen vorläufern
JPWO2008056481A1 (ja) * 2006-11-09 2010-02-25 日本メジフィジックス株式会社 放射性画像診断剤
RU2445120C2 (ru) 2006-12-21 2012-03-20 Нихон Меди-Физикс Ко., Лтд. Радиоактивный агент для диагностической визуализации
US8343459B2 (en) 2007-02-13 2013-01-01 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
TW200918102A (en) * 2007-10-24 2009-05-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
CA2704172A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Use of novel compound having affinity for amyloid, and process for production of the same
JPWO2009057577A1 (ja) * 2007-10-30 2011-03-10 日本メジフィジックス株式会社 新規アミロイド親和性化合物の使用及び製造方法
EP2214722A1 (de) * 2007-11-07 2010-08-11 GE Healthcare BV Stabilisierung von radiopharmaka
EP2419096B1 (de) 2009-04-15 2019-11-13 Lantheus Medical Imaging, Inc. Stabilisierung von radiopharmazeutischen zusammensetzungen mit ascorbinsäure
WO2012021882A2 (en) * 2010-08-13 2012-02-16 Siemens Medical Solutions Usa, Inc. Formulation, apparatus and method for stabilizing radiopharmaceuticals
DK2658831T3 (en) 2010-12-29 2017-04-24 Ge Healthcare Ltd elution
US20130005958A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20130004414A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20150231249A1 (en) * 2011-12-21 2015-08-20 Ge Healthcare Limited 18f-fluciclovine compositions in citrate buffers
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
GB202005282D0 (en) * 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
SE9002117L (sv) * 1990-06-14 1991-08-26 Nils Elander Mikrovaagsanordning foer behandling av precessvaetskor
JP3370666B2 (ja) 1990-07-06 2003-01-27 マリンクロッド・インコーポレイテッド 放射性レニウム錯体溶液の調製法
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
BE1010280A3 (fr) * 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
AU736481C (en) * 1996-10-07 2002-06-06 Du Pont Pharmaceuticals Company Radiopharmaceuticals for imaging infection and inflammation

Also Published As

Publication number Publication date
WO2003090789A1 (en) 2003-11-06
EP1496946B1 (de) 2009-02-18
US8182788B2 (en) 2012-05-22
EP1356827A1 (de) 2003-10-29
AU2003225124A1 (en) 2003-11-10
PL371682A1 (en) 2005-06-27
US20050175536A1 (en) 2005-08-11
JP2006500319A (ja) 2006-01-05
EP1496946A1 (de) 2005-01-19
KR20050005456A (ko) 2005-01-13
JP2010248244A (ja) 2010-11-04
IL164805A0 (en) 2005-12-18
JP5132869B2 (ja) 2013-01-30
CA2483181C (en) 2011-06-28
CN1323724C (zh) 2007-07-04
ATE422903T1 (de) 2009-03-15
NO20045070L (no) 2004-11-22
NO329160B1 (no) 2010-08-30
CA2483181A1 (en) 2003-11-06
AU2003225124B2 (en) 2007-06-14
IL164805A (en) 2009-06-15
CN1646175A (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
DE60326220D1 (de) Verfahren zur herstellung von einer 2-18f-fluor-2-deoxy-d-glucose (18fdg)-lösung
DE60239072D1 (de) Verfahren zur herstellung von glutaminsäurederivaten
ATE226222T1 (de) Epoxidharzzusammensetzung und verfahren zur herstellung von silanmodifizierten epoxidharzen
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE543817T1 (de) Verfahren zur herstellung einer imidverbindung
ATE328965T1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
DE60111732D1 (de) Verfahren zur herstellung von substituierten benzimidazolverbindungen
ATE268749T1 (de) Verfahren zur herstellung von iopamidol
BRPI0409069A (pt) compostos quìmicos
ATE428730T1 (de) Verfahren zur herstellung einer alpha-1- antitrypsinlösung
DE69940833D1 (de) Verfahren zur Herstellung von Arylethern
ATE554083T1 (de) Verfahren zur herstellung eines säureadditionssalzes einer polyaciden basenverbindung
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
ATE151729T1 (de) Verfahren zur herstellung titanhaltiger zeolithe
WO2006080043A3 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
DE60216931D1 (de) Verfahren zur herstellung von bisphenol-a
ATE411270T1 (de) Verfahren zur herstellung von optisch aktiven cyclohexenonen
DE60213998D1 (de) Verfahren zur herstellung von 2 oxocarbonsäureestern
ATE251121T1 (de) Verfahren zur herstellung von 1,3,6- hexantricarbonitril
ATE544738T1 (de) Verfahren zur herstellung von ä18füfluoralkylhalogeniden
DE502004012012D1 (de) Desinfektionsmittelkonzentrate auf Basis quaternärer Ammoniumverbindungen sowie die Verwendung derselben zur chemothermischen Instrumentenaufbereitung
DE69004320D1 (de) Hydroxyphenethylamin-Derivat und dessen Salze, Verfahren zur Herstellung, medizinische Verwendung und Verwendung als spezifisches pharmakologisches Werkzeug.
DE58901557D1 (de) Verfahren zur herstellung von 1,2-disulfon-verbindungen.
DE602006014951D1 (de) Verfahren zur herstellung von 2,3,4-trifluor-5-(iod- oder -brom)benzoesäure
DE502004009249D1 (de) (3,5-diaminophenyl)(2,4-dihydroxy-phenyl)methanon und dessen säureaddukte, verfahren zu deren herstellung und die verwendung dieser verbindungen zur färbung von fasern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition